Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecapegfilgrastim for Neutropenia in NSCLC
NCT01560195Phase 3Unknown
- Sponsor
- Hengrui
- Start
- Apr 2012
- Primary completion
- Jan 2013
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of mecapegfilgrastim in neutropenia, sponsored by Hengrui. Status: unknown.
02
Drugs
mecapegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01560195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560195.